Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys (Q42456843)

31 October 2017

Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys (English)

1 reference

31 October 2017

1 reference

Hurley SD

1

1 reference

31 October 2017

O'Banion MK

2

1 reference

31 October 2017

Song DD

3

1 reference

31 October 2017

Arana FS

4

1 reference

31 October 2017

Olschowka JA

5

1 reference

31 October 2017

Haber SN

6

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

31 October 2017

Experimental Neurology

1 reference

31 October 2017

184

1 reference

31 October 2017

2

1 reference

31 October 2017

659-668

1 reference

Rapid activation of microglial cells by hypoxia, kainic acid, and potassium ions in slice preparations of the rat hippocampus

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Regional and temporal characterization of neuronal, glial, and axonal response after traumatic brain injury in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Microglial reaction in the rat cerebral cortex induced by cortical spreading depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Brain glia release factors with opposing actions upon neuronal survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Microglial activation by purines and pyrimidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Wallerian degeneration induces Ia-antigen expression in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Microglia: a sensor for pathological events in the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Rate of cell death in parkinsonism indicates active neuropathological process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Expression of the histocompatibility glycoprotein HLA-DR in neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Characterization of microglial reaction after middle cerebral artery occlusion in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

MHC class II-positive microglia in human brain: association with Alzheimer lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Calcitonin gene-related peptide and ATP induce immediate early gene expression in cultured rat microglial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Neurochemical findings in the MPTP model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Microglial expression of MHC class II increases in normal aging of nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Increased microglial activation and protein nitration in white matter of the aging monkey☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Functional plasticity of microglia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

7 January 2021

Reactive microgliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

The role of glial cells in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Differential activation of microglia after experimental spinal cord injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900273-5

10.1016/S0014-4886(03)00273-5

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference